We do not display all the achieved goals on the graph, you can get detailed information about the achieved goals in the corresponding section on this page
The graph is interactive. When you hover over the icons of the achieved goals, you can see where the forecast was created.
Stock ticker: | MRK |
Name: | MERCK & CO., INC. |
Sector: | Healthcare |
Investing Risk: | MEDIUM |
Forecast length: | 24 days |
Accuracy: | 53.41 % |
Average profit per target: | 9.4 % |
Signal Date | Signal Price | Date Reached | Price Reached | Profit | Direction |
---|---|---|---|---|---|
2022-04-27 | 76.69 $ | 2022-11-22 | 98.71 $ | 28.71% | |
2022-05-05 | 79.96 $ | 2022-12-14 | 103.69 $ | 29.67% | |
2022-05-06 | 80.31 $ | 2022-12-14 | 103.69 $ | 29.11% | |
2022-05-09 | 79.63 $ | 2022-12-14 | 103.69 $ | 30.22% | |
2022-05-10 | 79.78 $ | 2022-12-14 | 103.69 $ | 29.96% | |
2022-05-11 | 81.04 $ | 2022-12-14 | 103.69 $ | 27.95% | |
2022-05-12 | 82.53 $ | 2022-12-08 | 102.36 $ | 24.03% | |
2022-05-13 | 82.14 $ | 2022-12-08 | 102.36 $ | 24.61% | |
2022-05-16 | 83.88 $ | 2022-12-08 | 102.36 $ | 22.03% | |
2022-05-17 | 84.5 $ | 2022-11-28 | 100.14 $ | 18.52% | |
2022-05-18 | 83.68 $ | 2022-11-25 | 99.27 $ | 18.62% | |
2022-05-25 | 85.18 $ | 2022-12-14 | 103.69 $ | 21.73% | |
2022-06-01 | 82.81 $ | 2022-11-28 | 100.14 $ | 20.93% | |
2022-06-03 | 81.69 $ | 2022-11-22 | 98.71 $ | 20.84% | |
2022-06-07 | 82.21 $ | 2022-11-28 | 100.14 $ | 21.82% | |
2022-06-08 | 81.3 $ | 2022-11-28 | 100.14 $ | 23.18% | |
2022-06-10 | 79.21 $ | 2022-12-14 | 103.69 $ | 30.9% | |
2022-06-13 | 77.23 $ | 2022-12-14 | 103.69 $ | 34.26% | |
2022-06-14 | 77.4 $ | 2023-01-06 | 106.75 $ | 37.91% | |
2022-06-15 | 77.52 $ | 2023-01-06 | 106.75 $ | 37.7% | |
2022-06-16 | 77.76 $ | 2023-01-06 | 106.75 $ | 37.28% | |
2022-06-17 | 77.51 $ | 2023-01-06 | 106.75 $ | 37.71% | |
2022-06-21 | 80.64 $ | 2023-01-06 | 106.75 $ | 32.38% | |
2022-06-23 | 84.27 $ | 2023-01-05 | 105.63 $ | 25.34% | |
2022-06-28 | 84.17 $ | 2023-04-13 | 108.18 $ | 28.52% | |
2022-07-07 | 85.2 $ | 2023-05-02 | 110.34 $ | 29.51% | |
2023-07-03 | 107.73 $ | 2024-03-27 | 126.69 $ | 17.6% | |
2023-09-05 | 101.3 $ | 2024-01-29 | 115.89 $ | 14.4% | |
2024-12-24 | 97.62 $ | 2025-02-06 | 86.43 $ | 11.46% | |
2024-12-31 | 97.65 $ | 2025-02-06 | 86.43 $ | 11.49% | |
2025-02-28 | 90.55 $ | 2025-04-04 | 80.66 $ | 10.92% | |
2025-03-04 | 90.86 $ | 2025-04-16 | 75.7 $ | 16.68% | |
2025-03-07 | 92.91 $ | 2025-05-14 | 72.74 $ | 21.71% | |
2025-03-11 | 92.99 $ | 2025-05-14 | 72.74 $ | 21.77% | |
2025-03-27 | 86.73 $ | 2025-05-14 | 72.74 $ | 16.13% |
MRK Merck & Co., Inc. has recently received FDA approval to expand the use of its top-selling drug Keytruda. This news has led to positive expectations for the company's future performance....
Merck & Co., Inc. (MRK) has been recognized as one of the top dividend contenders in the market, according to Yahoo Finance....
Merck Co. Inc. (MRK) has emerged as a top pick among investors looking for stable and reliable stocks....
Shareholders that lost money on Merck & Co. Inc. (MRK) are being urged to join a class action against the company....
Merck & Co., Inc., commonly known as Merck, has emerged as one of the most undervalued stocks in the US market, as indicated by leading hedge funds....
Merck & Co. (MRK), one of the leading pharmaceutical companies, has announced the opening of its state-of-the-art $1 billion Next-Generation Vaccine Facility....
Merck & Co., Inc., commonly known as Merck, is a global healthcare company that develops and markets innovative pharmaceutical, vaccine, biologic, and animal health products....
Merck & Co., Inc. (MRK) is set to present its strategic update at the upcoming TD Cowen Healthcare Conference....
Investors of MRK Merck & Co. Inc. have been urged by ROSEN HIGHLY RECOGNIZED INVESTOR COUNSEL to seek legal representation before the critical deadline related to a securities class action....
Merck & Co., Inc. (NYSE: MRK) has caught the attention of investors as a potential investment opportunity....